Aeterna Zentaris Inc
c/o Norton Rose Fulbright Canada, LLP222 Bay Street , Suite 3000
Toronto ON M5K 1E7 CAN
P: 416-216-4000
https://www.zentaris.com
Sectors & Indices
Sector
Industry
Employees
Profile
AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license agreement with Novo Nordisk & the company receives royalties on sales. Aeterna owns all rights to macimorelin outside of the U.S. & Canada. It is leveraging the clinical success & safety profile of macimorelin to develop it for the diagnosis of child-onset GHD. The company's geographical segments include Switzerland which generates key revenue, Ireland, Denmark, and others.
Key Executives
Name | Title |
---|---|
Michael Teifel | Chief Scientific Officer/Senior VP, Divisional |
Nicola Ammer | Chief Medical Officer/Senior VP, Divisional |
Klaus Paulini | CEO/Director/Managing Director, Subsidiary/President |
Matthias Gerlach | Senior VP, Divisional |
Giuliano La Fratta | CFO/Senior VP |